These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

386 related articles for article (PubMed ID: 35844506)

  • 1. Immunogenic Cell Death and Role of Nanomaterials Serving as Therapeutic Vaccine for Personalized Cancer Immunotherapy.
    Catanzaro E; Feron O; Skirtach AG; Krysko DV
    Front Immunol; 2022; 13():925290. PubMed ID: 35844506
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An emerging role for nanomaterials in increasing immunogenicity of cancer cell death.
    Mishchenko T; Mitroshina E; Balalaeva I; Krysko O; Vedunova M; Krysko DV
    Biochim Biophys Acta Rev Cancer; 2019 Jan; 1871(1):99-108. PubMed ID: 30528646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The application of nanoparticles-based ferroptosis, pyroptosis and autophagy in cancer immunotherapy.
    Deng W; Shang H; Tong Y; Liu X; Huang Q; He Y; Wu J; Ba X; Chen Z; Chen Y; Tang K
    J Nanobiotechnology; 2024 Mar; 22(1):97. PubMed ID: 38454419
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current status of nanoparticle-mediated immunogenic cell death in cancer immunotherapy.
    Hiep Tran T; Thu Phuong Tran T
    Int Immunopharmacol; 2024 Dec; 142(Pt A):113085. PubMed ID: 39276455
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanomedicines for an Enhanced Immunogenic Cell Death-Based
    Zhao C; Wang C; Shan W; Wang Z; Chen X; Deng H
    Acc Chem Res; 2024 Mar; 57(6):905-918. PubMed ID: 38417027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanomaterials: leading immunogenic cell death-based cancer therapies.
    Ma C; Cheng Z; Tan H; Wang Y; Sun S; Zhang M; Wang J
    Front Immunol; 2024; 15():1447817. PubMed ID: 39185425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunogenic cell death-based cancer vaccines: promising prospect in cancer therapy.
    Wang J; Ma J; Xie F; Miao F; Lv L; Huang Y; Zhang X; Yu J; Tai Z; Zhu Q; Bao L
    Front Immunol; 2024; 15():1389173. PubMed ID: 38745666
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunogenic cell death in cancer immunotherapy.
    Choi M; Shin J; Lee CE; Chung JY; Kim M; Yan X; Yang WH; Cha JH
    BMB Rep; 2023 May; 56(5):275-286. PubMed ID: 37081756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Natural Compounds of Marine Origin as Inducers of Immunogenic Cell Death (ICD): Potential Role for Cancer Interception and Therapy.
    Sansone C; Bruno A; Piscitelli C; Baci D; Fontana A; Brunet C; Noonan DM; Albini A
    Cells; 2021 Jan; 10(2):. PubMed ID: 33504012
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer Immunotherapy Elicited by Immunogenic Cell Death Based on Smart Nanomaterials.
    Yang M; Zhang C; Wang R; Wu X; Li H; Yoon J
    Small Methods; 2023 May; 7(5):e2201381. PubMed ID: 36609838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The intrinsic immunogenic properties of cancer cell lines, immunogenic cell death, and how these influence host antitumor immune responses.
    Aaes TL; Vandenabeele P
    Cell Death Differ; 2021 Mar; 28(3):843-860. PubMed ID: 33214663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sensitize Tumor Immunotherapy: Immunogenic Cell Death Inducing Nanosystems.
    Peng J; Li S; Ti H
    Int J Nanomedicine; 2024; 19():5895-5930. PubMed ID: 38895146
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nanomedicine to aid immunogenic cell death (ICD)-based anticancer therapy.
    Demuynck R; Engelen Y; Skirtach AG; De Smedt SC; Lentacker I; Krysko DV
    Trends Cancer; 2024 Jun; 10(6):486-489. PubMed ID: 38553361
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CX3CL1 release during immunogenic apoptosis is associated with enhanced anti-tumour immunity.
    Naessens F; Demuynck R; Vershinina O; Efimova I; Saviuk M; De Smet G; Mishchenko TA; Vedunova MV; Krysko O; Catanzaro E; Krysko DV
    Front Immunol; 2024; 15():1396349. PubMed ID: 39011040
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaccination with early ferroptotic cancer cells induces efficient antitumor immunity.
    Efimova I; Catanzaro E; Van der Meeren L; Turubanova VD; Hammad H; Mishchenko TA; Vedunova MV; Fimognari C; Bachert C; Coppieters F; Lefever S; Skirtach AG; Krysko O; Krysko DV
    J Immunother Cancer; 2020 Nov; 8(2):. PubMed ID: 33188036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting immunogenic cancer cell death by photodynamic therapy: past, present and future.
    Alzeibak R; Mishchenko TA; Shilyagina NY; Balalaeva IV; Vedunova MV; Krysko DV
    J Immunother Cancer; 2021 Jan; 9(1):. PubMed ID: 33431631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell death and immunity in cancer: From danger signals to mimicry of pathogen defense responses.
    Garg AD; Agostinis P
    Immunol Rev; 2017 Nov; 280(1):126-148. PubMed ID: 29027218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interrelation between Programmed Cell Death and Immunogenic Cell Death: Take Antitumor Nanodrug as an Example.
    Meng Q; Ding B; Ma P; Lin J
    Small Methods; 2023 May; 7(5):e2201406. PubMed ID: 36707416
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trial watch: chemotherapy-induced immunogenic cell death in immuno-oncology.
    Vanmeerbeek I; Sprooten J; De Ruysscher D; Tejpar S; Vandenberghe P; Fucikova J; Spisek R; Zitvogel L; Kroemer G; Galluzzi L; Garg AD
    Oncoimmunology; 2020; 9(1):1703449. PubMed ID: 32002302
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nanomaterials-Based Photodynamic Therapy with Combined Treatment Improves Antitumor Efficacy Through Boosting Immunogenic Cell Death.
    Jin F; Liu D; Xu X; Ji J; Du Y
    Int J Nanomedicine; 2021; 16():4693-4712. PubMed ID: 34267518
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.